(20 August 2013) – The European Commission awards its 50th European Industrial Doctorate (EID) research grant today. The €1.5 million grant is for research into new antibodies that will destroy a tumour’s blood vessels and eradicate the tumour.
The so-called VAMPIRE project (‘Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection’) is led by the University of Birmingham in the UK and SomantiX, a Dutch biotech company based in Utrecht.
The research is supported by associated European universities, companies and research centres including Swiss science and technology university ETH Zurich and the charity Cancer Research UK. The EID scheme is targeted at projects which bring together business and academic partners in two countries.
The European Industrial Doctorate was launched as a pilot project in 2012 as part of the Marie Curie Actions (MCA), the European research fellowship programme. The aim of the EID scheme is to provide PhD candidates with professional experience in excellent research projects, as well as to attract more young people into scientific careers.